EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Pure red cell aplasia in a patient with rheumatoid arthritis after JAK inhibitor exposure—diagnostic challenges

Shashi Rajnarinesingh, Maria Georgiou, Nita Prasannan, Priya Sriskandarajah iD

Oxford Medical Case Reports · 08.07.2026 · 2026 (7)

DOI: 10.1093/omcr/omag125 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oxford Medical Case Reports, online erschienen am 12.07.2026. Verfasst von Shashi Rajnarinesingh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Guy's Hospital, London SE1 9RT, United Kingdom. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe a patient with long-standing rheumatoid arthritis (RA) who developed severe refractory transfusion-dependent anaemia lasting several months following treatment with a JAK1 inhibitor (Filgotinib). The patient proceeded with extensive investigations, including bone marrow assessment, and was initially diagnosed with Filgotinib-associated anaemia. However, despite stopping this agent, the anaemia persisted with fluctuating reticulocyte count resulting in multiple hospital admissions. Although the anaemia was initially attributed to Filgotinib, its persistence alongside delayed reticulocytopenia, ultimately led to a diagnosis of acquired Pure Red Cell Aplasia more than 12 months later. Complete remission was achieved with prednisolone + ciclosporin A. This case underscores the need to consider PRCA in RA patients on JAK inhibitors even with initially normal reticulocyte counts, as these agents may transiently mask underlying aplasia.

Schlagwörter

Stichwörter der Autor:innen

JAK inhibitorhaematologyred cell aplasiarheumatoid arthritisrheumatology

Autor:innen und Institutionen

  • Department of Haematology, Guy's Hospital, London SE1 9RT, United Kingdom.

ORCID-Profile: Priya Sriskandarajah

Zitieren

APA

Rajnarinesingh, S., Georgiou, M., Prasannan, N., & Sriskandarajah, P. (2026). Pure red cell aplasia in a patient with rheumatoid arthritis after JAK inhibitor exposure—diagnostic challenges. Oxford Medical Case Reports, 2026(7). https://doi.org/10.1093/omcr/omag125

Vancouver

Rajnarinesingh S, Georgiou M, Prasannan N, Sriskandarajah P. Pure red cell aplasia in a patient with rheumatoid arthritis after JAK inhibitor exposure—diagnostic challenges. Oxford Medical Case Reports. 2026;2026(7). doi:10.1093/omcr/omag125

BibTeX
@article{Rajnarinesingh2026,
  author = {Rajnarinesingh, Shashi and Georgiou, Maria and Prasannan, Nita and Sriskandarajah, Priya},
  title = {Pure red cell aplasia in a patient with rheumatoid arthritis after JAK inhibitor exposure—diagnostic challenges},
  journal = {Oxford Medical Case Reports},
  year = {2026},
  volume = {2026},
  number = {7},
  doi = {10.1093/omcr/omag125}
}
Kostenlos starten →